Publications
October 10, 2026

39th European College of Neuropsychopharmacology (ECNP) Congress

Poster: Targeting γ1-containing GABA-A receptors spares γ2-benzodiazepine mediated neurophysiological impairments in human volunteers

October 10, 2026

39th European College of Neuropsychopharmacology (ECNP) Congress

Poster: Moderators of placebo effect in Generalized Anxiety Disorder (GAD) trials: a meta-regression analysis

October 10, 2026

39th European College of Neuropsychopharmacology (ECNP) Congress

Poster: Spectral EEG distributions in generalized anxiety disorder using a large hospital-based clinical EEG database

May 26, 2026

American Society of Clinical Psychopharmacology (ASCP), 2026 Annual Meeting

Presentation: A New Dawn for Social Anxiety Treatment: Clinical Advancement of the Novel V1aR Antagonist, NTX-1472

May 2026

American Society of Clinical Psychopharmacology (ASCP), 2026 Annual Meeting

Poster: A New Dawn for Social Anxiety Treatment: Clinical Advancement of the Novel V1aR Antagonist, NTX-1472

April 2026

Anxiety & Depression Association of America (ADAA), 2026 Annual Conference

Poster: A New Dawn for Social Anxiety Treatment: Clinical Advancement of the Novel V1aR Antagonist, NTX-1472